Gladstone Institutional Advisory’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-10,500
| Closed | -$17.1K | – | 720 |
|
|
2023
Q1 | $17.1K | Hold |
10,500
| – | – | ﹤0.01% | 651 |
|
|
2022
Q4 | $14K | Sell |
10,500
-25,000
| -70% | -$33.3K | ﹤0.01% | 640 |
|
|
2022
Q3 | $55K | Hold |
35,500
| – | – | ﹤0.01% | 620 |
|
|
2022
Q2 | $55K | Hold |
35,500
| – | – | ﹤0.01% | 635 |
|
|
2022
Q1 | $91K | Hold |
35,500
| – | – | 0.01% | 680 |
|
|
2021
Q4 | $104K | Sell |
35,500
-18,000
| -34% | -$52.7K | 0.01% | 580 |
|
|
2021
Q3 | $131K | Buy |
53,500
+5,000
| +10% | +$12.2K | 0.01% | 516 |
|
|
2021
Q2 | $197K | Hold |
48,500
| – | – | 0.02% | 486 |
|
|
2021
Q1 | $219K | Sell |
48,500
-3,000
| -6% | -$13.5K | 0.03% | 371 |
|
|
2020
Q4 | $253K | Buy |
+51,500
| New | +$253K | 0.05% | 256 |
|